Drug Profile
AE 941
Alternative Names: Arthrovas; Neoretna; Neovastat; Psovascar; Shark cartilage extract AE 941Latest Information Update: 17 Aug 2017
Price :
$50
*
At a glance
- Originator AEterna Zentaris Inc
- Class Antineoplastics; Antipsoriatics
- Mechanism of Action Angiogenesis inhibitors; Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Age-related macular degeneration; Breast cancer; Multiple myeloma; Non-small cell lung cancer; Osteoarthritis; Prostate cancer; Psoriasis; Renal cancer; Rheumatoid arthritis
Most Recent Events
- 05 Mar 2007 Discontinued - Phase-III for Non-small cell lung cancer in Canada (PO)
- 05 Mar 2007 Discontinued - Phase-III for Non-small cell lung cancer in USA (PO)
- 17 Feb 2006 The US National Cancer Institute has interrupted enrolment in a phase III trial for Non-small cell lung cancer in the USA and Canada